Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TOMDF

Todos Med (CE) (TOMDF)

Todos Med Ltd (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:TOMDF
DateTimeSourceHeadlineSymbolCompany
12:49PMiHub NewswireFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
07/17/20238:29AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:TOMDFTodos Med Ltd (CE)
05/16/20233:07PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:TOMDFTodos Med Ltd (CE)
03/31/20234:04PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
03/31/20234:04PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:TOMDFTodos Med Ltd (CE)
03/29/20232:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TOMDFTodos Med Ltd (CE)
03/15/202310:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:TOMDFTodos Med Ltd (CE)
09/13/20224:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
09/13/20226:02AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:TOMDFTodos Med Ltd (CE)
09/01/20229:21AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
08/24/202212:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TOMDFTodos Med Ltd (CE)
08/22/20224:05PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TOMDFTodos Med Ltd (CE)
08/22/20224:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:TOMDFTodos Med Ltd (CE)
08/15/20224:33PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:TOMDFTodos Med Ltd (CE)
08/12/20224:05PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:TOMDFTodos Med Ltd (CE)
08/10/20224:41PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
08/05/20224:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
08/03/20229:48AMInvestorsHub NewsWireTodos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista DiagnosticsUSOTC:TOMDFTodos Med Ltd (CE)
05/16/20225:14PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:TOMDFTodos Med Ltd (CE)
04/06/20223:59PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TOMDFTodos Med Ltd (CE)
03/31/20226:17PMEdgar (US Regulatory)Annual Report (10-k)USOTC:TOMDFTodos Med Ltd (CE)
03/17/20226:05AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
02/07/20226:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:TOMDFTodos Med Ltd (CE)
01/27/20228:30AMInvestorsHub NewsWireTodos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 PatientsUSOTC:TOMDFTodos Med Ltd (CE)
01/18/20224:04PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:TOMDFTodos Med Ltd (CE)
12/02/202110:39AMInvestorsHub NewsWireSA Breaking News - PURA expects to sign first contracts this monthUSOTC:TOMDFTodos Med Ltd (CE)
11/29/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
11/16/20216:09AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
10/22/20213:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
09/27/20216:06AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
 Showing the most relevant articles for your search:USOTC:TOMDF